This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
| adjective | noun | frequency |
|---|---|---|
| - | cov-2 | 696 |
| - | cov | 621 |
| antiviral | activity | 174 |
| viral | rna | 141 |
| - | cell | 140 |
| infected | cells | 136 |
| - | infection | 107 |
| - | time | 86 |
| viral | replication | 86 |
| - | pedv | 72 |
| viral | infection | 66 |
| novel | coronavirus | 65 |
| viral | entry | 60 |
| human | coronavirus | 52 |
| viral | proteins | 44 |
| infectious | virus | 44 |
| different | cell | 42 |
| viral | protein | 40 |
| antiviral | effect | 39 |
| infected | vero | 37 |
| antiviral | activities | 35 |
| - | sars | 31 |
| - | c | 26 |
| new | coronavirus | 22 |
| significant | . | 22 |
| - | coronavirus | 21 |
| different | time | 21 |
| other | viruses | 21 |
| humans | . | 20 |
| viral | infections | 20 |
| dependent | rna | 20 |
| antiviral | effects | 19 |
| recombinant | virus | 17 |
| human | cell | 16 |
| other | cell | 15 |
| infected | cell | 14 |
| recombinant | viruses | 11 |
| human | cells | 10 |
| cellular | rna | 10 |
| porcine | cell | 9 |
| first | time | 8 |
| new | cell | 8 |
| respiratory | coronavirus | 8 |
| clinical | studies | 8 |
| cellular | entry | 8 |
| other | studies | 7 |
| viral | activity | 7 |
| cellular | proteins | 7 |
| infectious | sars | 7 |
| high | virus | 7 |
| - | entry | 6 |
| - | protein | 6 |
| dependent | . | 6 |
| higher | cell | 6 |
| higher | virus | 6 |
| infectious | viruses | 6 |
| viral | effects | 5 |
| respiratory | viruses | 5 |
| other | virus | 5 |
| viral | gene | 5 |
| recombinant | strains | 5 |
| other | strains | 5 |
| other | cells | 5 |
| new | virus | 5 |
| antivirals | . | 5 |
| antiviral | genes | 5 |
| - | vero | 5 |
| large | rna | 4 |
| specific | . | 4 |
| recombinant | coronavirus | 4 |
| others | . | 4 |
| other | genes | 4 |
| novel | virus | 4 |
| other | rna | 4 |
| infectious | pedv | 4 |
| cellular | protein | 4 |
| - | virus | 4 |
| - | lines | 4 |
| - | h | 4 |
| - | activity | 4 |
| first | line | 4 |
| similar | activity | 3 |
| other | sars | 3 |
| respiratory | infection | 3 |
| respiratory | infections | 3 |
| respiratory | virus | 3 |
| viral | cell | 3 |
| specific | rna | 3 |
| specific | viruses | 3 |
| such | studies | 3 |
| viral | genes | 3 |
| lower | . | 3 |
| infectious | activity | 3 |
| different | cells | 3 |
| largest | rna | 3 |
| dependent | protein | 3 |
| acute | infection | 3 |
| cellular | genes | 3 |
| human | infection | 3 |
| dependent | entry | 3 |
| clinical | study | 3 |
| different | . | 3 |
| different | effects | 3 |
| different | strains | 3 |
| human | . | 3 |
| other | pedv | 2 |
| lower | replication | 2 |
| lower | virus | 2 |
| new | pedv | 2 |
| new | viruses | 2 |
| novel | protein | 2 |
| novel | strain | 2 |
| other | infection | 2 |
| infectious | rna | 2 |
| recombinant | protein | 2 |
| recombinant | strain | 2 |
| severe | . | 2 |
| significant | effects | 2 |
| similar | . | 2 |
| similar | effect | 2 |
| specific | cell | 2 |
| viral | sequences | 2 |
| low | virus | 2 |
| infectious | . | 2 |
| infectious | entry | 2 |
| dependent | genes | 2 |
| human | viruses | 2 |
| - | cells | 2 |
| - | infections | 2 |
| - | rna | 2 |
| antiviral | studies | 2 |
| antivirals | studied | 2 |
| dependent | cell | 2 |
| - | line | 2 |
| different | pedv | 2 |
| first | sars | 2 |
| first | sequence | 2 |
| high | infection | 2 |
| human | gene | 2 |
| different | times | 2 |
| human | infections | 2 |
| porcine | viruses | 1 |
| other | vero | 1 |
| others | viruses | 1 |
| porcine | virus | 1 |
| recombinant | sars | 1 |
| recombinant | pedv | 1 |
| recombinant | proteins | 1 |
| recombinant | sequences | 1 |
| severe | infection | 1 |
| other | coronavirus | 1 |
| other | time | 1 |
| lowest | virus | 1 |
| other | . | 1 |
| novel | rna | 1 |
| novel | infections | 1 |
| novel | entry | 1 |
| novel | cells | 1 |
| new | rna | 1 |
| new | cells | 1 |
| similar | cell | 1 |
| lower | rna | 1 |
| lower | infection | 1 |
| lower | cell | 1 |
| significant | effect | 1 |
| specific | assay | 1 |
| similar | coronavirus | 1 |
| specific | genes | 1 |
| viral | sars | 1 |
| viral | activities | 1 |
| such | virus | 1 |
| such | cells | 1 |
| such | cell | 1 |
| specific | time | 1 |
| specific | sequences | 1 |
| specific | sequence | 1 |
| specific | proteins | 1 |
| specific | protein | 1 |
| specific | gene | 1 |
| similar | infection | 1 |
| specific | effects | 1 |
| specific | effect | 1 |
| specific | coronavirus | 1 |
| specific | c | 1 |
| low | infection | 1 |
| similar | time | 1 |
| similar | study | 1 |
| similar | studies | 1 |
| similar | rna | 1 |
| similar | replication | 1 |
| low | rna | 1 |
| humans | sars | 1 |
| low | activity | 1 |
| cellular | activities | 1 |
| different | assay | 1 |
| different | activity | 1 |
| dependent | virus | 1 |
| dependent | infection | 1 |
| dependent | effects | 1 |
| dependent | effect | 1 |
| clinical | strains | 1 |
| clinical | strain | 1 |
| clinical | sars | 1 |
| cellular | gene | 1 |
| antiviral | study | 1 |
| different | infection | 1 |
| antiviral | rna | 1 |
| antiviral | assays | 1 |
| acute | virus | 1 |
| acute | infections | 1 |
| - | viruses | 1 |
| - | sequenced | 1 |
| - | proteins | 1 |
| - | assayed | 1 |
| - | assay | 1 |
| - | . | 1 |
| different | gene | 1 |
| different | proteins | 1 |
| low | . | 1 |
| highest | sequence | 1 |
| largest | sars | 1 |
| large | protein | 1 |
| large | . | 1 |
| important | genes | 1 |
| important | cell | 1 |
| important | . | 1 |
| human | virus | 1 |
| human | sars | 1 |
| human | proteins | 1 |
| human | c | 1 |
| higher | c | 1 |
| different | sars | 1 |
| high | sequence | 1 |
| high | cell | 1 |
| full | rna | 1 |
| full | protein | 1 |
| full | activity | 1 |
| first | study | 1 |
| first | sequenced | 1 |
| first | pedv | 1 |
| different | viruses | 1 |
| different | virus | 1 |
| viral | strains | 1 |